Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2014

Open Access 01-12-2014 | Research article

Is pathology necessary to predict mortality among men with prostate-cancer?

Authors: David Margel, David R Urbach, Lorraine L Lipscombe, Chaim M Bell, Girish Kulkarni, Jack Baniel, Neil Fleshner, Peter C Austin

Published in: BMC Medical Informatics and Decision Making | Issue 1/2014

Login to get access

Abstract

Background

Statistical models developed using administrative databases are powerful and inexpensive tools for predicting survival. Conversely, data abstraction from chart review is time-consuming and costly. Our aim was to determine the incremental value of pathological data obtained from chart abstraction in addition to information acquired from administrative databases in predicting all-cause and prostate cancer (PC)-specific mortality.

Methods

We identified a cohort of men with diabetes and PC utilizing population-based data from Ontario. We used the c-statistic and net-reclassification improvement (NRI) to compare two Cox- proportional hazard models to predict all-cause and PC-specific mortality. The first model consisted of covariates from administrative databases: age, co-morbidity, year of cohort entry, socioeconomic status and rural residence. The second model included Gleason grade and cancer volume in addition to all aforementioned variables.

Results

The cohort consisted of 4001 patients. The accuracy of the admin-data only model (c-statistic) to predict 5-year all-cause mortality was 0.7 (95% CI 0.69-0.71). For the extended model (including pathology information) it was 0.74 (95% CI 0.73-0.75). This corresponded to a change in category of predicted probability of survival among 14.8% in the NRI analysis.
The accuracy of the admin-data model to predict 5-year PC specific mortality was 0.76 (95% CI 0.74-0.78). The accuracy of the extended model was 0.85 (95% CI 0.83-0.87). Corresponding to a 28% change in the NRI analysis.

Conclusions

Pathology chart abstraction, improved the accuracy in predicting all-cause and PC-specific mortality. The benefit is smaller for all-cause mortality, and larger for PC-specific mortality.
Literature
1.
go back to reference Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD: Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet. 2000, 356: 639-644. 10.1016/S0140-6736(00)02606-4.CrossRefPubMed Rochon PA, Tu JV, Anderson GM, Gurwitz JH, Clark JP, Lau P, Szalai JP, Sykora K, Naylor CD: Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction. Lancet. 2000, 356: 639-644. 10.1016/S0140-6736(00)02606-4.CrossRefPubMed
2.
go back to reference Soumerai SB, McLauglin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L: Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997, 277: 115-121. 10.1001/jama.1997.03540260029031.CrossRefPubMed Soumerai SB, McLauglin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L: Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997, 277: 115-121. 10.1001/jama.1997.03540260029031.CrossRefPubMed
3.
go back to reference Mamdani MM, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, Austin PC, Laupacis A: Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase- inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ. 2002, 325: 624-10.1136/bmj.325.7365.624.CrossRefPubMedPubMedCentral Mamdani MM, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, Austin PC, Laupacis A: Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase- inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ. 2002, 325: 624-10.1136/bmj.325.7365.624.CrossRefPubMedPubMedCentral
4.
go back to reference McClellan M, McNeil BJ, Newhouse JP: Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality?. JAMA. 1994, 272: 859-866. 10.1001/jama.1994.03520110039026.CrossRefPubMed McClellan M, McNeil BJ, Newhouse JP: Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality?. JAMA. 1994, 272: 859-866. 10.1001/jama.1994.03520110039026.CrossRefPubMed
5.
go back to reference Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P: Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011, 29: 3163-3172. 10.1200/JCO.2010.33.1595.CrossRefPubMed Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P: Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol. 2011, 29: 3163-3172. 10.1200/JCO.2010.33.1595.CrossRefPubMed
6.
go back to reference Kattan MW, Karpeh MS, Mazumdar M, Brennan MF: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003, 21: 3647-3650. 10.1200/JCO.2003.01.240.CrossRefPubMed Kattan MW, Karpeh MS, Mazumdar M, Brennan MF: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003, 21: 3647-3650. 10.1200/JCO.2003.01.240.CrossRefPubMed
7.
go back to reference Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL: Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005, 23: 7529-7535. 10.1200/JCO.2005.01.8101.CrossRefPubMedPubMedCentral Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL: Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005, 23: 7529-7535. 10.1200/JCO.2005.01.8101.CrossRefPubMedPubMedCentral
8.
go back to reference Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007, 25: 3991-4008. 10.1200/JCO.2007.10.9777.CrossRefPubMed Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007, 25: 3991-4008. 10.1200/JCO.2007.10.9777.CrossRefPubMed
9.
go back to reference Seigel R, Ward E, Brawley O, Jemal A: Cancer Statistics, 2011. CA Cancer J Clin. 2011, 61: 212-236. 10.3322/caac.20121.CrossRef Seigel R, Ward E, Brawley O, Jemal A: Cancer Statistics, 2011. CA Cancer J Clin. 2011, 61: 212-236. 10.3322/caac.20121.CrossRef
10.
go back to reference GLOBOCAN: Prostate Cancer Incidence and Mortality Worldwide in 2008. 2008. GLOBOCAN: Prostate Cancer Incidence and Mortality Worldwide in 2008. 2008.
11.
go back to reference Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K: Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA. 2006, 296: 2683-2693. 10.1001/jama.296.22.2683.CrossRefPubMed Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K: Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA. 2006, 296: 2683-2693. 10.1001/jama.296.22.2683.CrossRefPubMed
12.
go back to reference Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA: Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?. Eur J Cancer. 2012, 48: 1664-1671. 10.1016/j.ejca.2012.01.026.CrossRefPubMed Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA: Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?. Eur J Cancer. 2012, 48: 1664-1671. 10.1016/j.ejca.2012.01.026.CrossRefPubMed
13.
go back to reference Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur Urol. 2011, 60: 920-930. 10.1016/j.eururo.2011.06.039.CrossRefPubMed Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur Urol. 2011, 60: 920-930. 10.1016/j.eururo.2011.06.039.CrossRefPubMed
14.
go back to reference Shetti MB, Merrick GS, Butler WM, Galbreath R, Torlone A, Lief JH, Adamovich E, Wallner KE: The Impact of Diabetes Mellitus on Survival in Men With Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy. Am J Clin Oncol. 2011, 29: 222-232. 10.1200/JCO.2010.32.1927.CrossRef Shetti MB, Merrick GS, Butler WM, Galbreath R, Torlone A, Lief JH, Adamovich E, Wallner KE: The Impact of Diabetes Mellitus on Survival in Men With Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy. Am J Clin Oncol. 2011, 29: 222-232. 10.1200/JCO.2010.32.1927.CrossRef
15.
go back to reference Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS: Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer. J Gen Intern Med. 2012, 27: 492-499. 10.1007/s11606-011-1869-4.CrossRefPubMed Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS: Comorbidities, Treatment and Ensuing Survival in Men with Prostate Cancer. J Gen Intern Med. 2012, 27: 492-499. 10.1007/s11606-011-1869-4.CrossRefPubMed
16.
go back to reference Margel D, Urbach D, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N: Metformin and prostate cancer and all-cause mortality among diabetic men. JCO. 2013, 31: 3069-3075. 10.1200/JCO.2012.46.7043.CrossRef Margel D, Urbach D, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N: Metformin and prostate cancer and all-cause mortality among diabetic men. JCO. 2013, 31: 3069-3075. 10.1200/JCO.2012.46.7043.CrossRef
17.
go back to reference Robles SC, Marrett LD, Clarke EA, Risch HA: An application of capture recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988, 41: 495-501. 10.1016/0895-4356(88)90052-2.CrossRefPubMed Robles SC, Marrett LD, Clarke EA, Risch HA: An application of capture recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988, 41: 495-501. 10.1016/0895-4356(88)90052-2.CrossRefPubMed
18.
go back to reference Williams JI, Young W: A summary of studies on the quality of health care administrative databases in Canada. Patterns of Health Care in Ontario. The ICES Practice Atlas. Edited by: Goel V, Williams JI, Anderson GM, Blacksterin-Hirsch P, Fooks C, Naylor CD. 1996, Canadian Medical Association, Ottawa, ON, 339-345. Williams JI, Young W: A summary of studies on the quality of health care administrative databases in Canada. Patterns of Health Care in Ontario. The ICES Practice Atlas. Edited by: Goel V, Williams JI, Anderson GM, Blacksterin-Hirsch P, Fooks C, Naylor CD. 1996, Canadian Medical Association, Ottawa, ON, 339-345.
19.
go back to reference Juurlink D, Preyra C, Croxford R, et al: Canadian Institute for Health Information Discharge Abstract Database: a validation study. 2006, Toronto (ON), Institute for Clinical Evaluative Sciences Juurlink D, Preyra C, Croxford R, et al: Canadian Institute for Health Information Discharge Abstract Database: a validation study. 2006, Toronto (ON), Institute for Clinical Evaluative Sciences
20.
go back to reference Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25: 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25: 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed
21.
go back to reference Brenner DR, Tammemägi MC, Bull SB, Pinnaduwaje D, Andrulis IL: Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients. Chronic Dis Can. 2009, 30: 16-19.PubMed Brenner DR, Tammemägi MC, Bull SB, Pinnaduwaje D, Andrulis IL: Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients. Chronic Dis Can. 2009, 30: 16-19.PubMed
22.
go back to reference Hall S, Schulze K, Groome P, Mackillop W, Holowaty E: Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol. 2006, 59: 67-76. 10.1016/j.jclinepi.2005.05.001.CrossRefPubMed Hall S, Schulze K, Groome P, Mackillop W, Holowaty E: Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol. 2006, 59: 67-76. 10.1016/j.jclinepi.2005.05.001.CrossRefPubMed
23.
go back to reference Schouten LJ, Jager JJ, van den Brandt PA: Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993, 68: 974-977. 10.1038/bjc.1993.464.CrossRefPubMedPubMedCentral Schouten LJ, Jager JJ, van den Brandt PA: Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993, 68: 974-977. 10.1038/bjc.1993.464.CrossRefPubMedPubMedCentral
24.
go back to reference Austin PC, Walraven C: The mortality risk score and the ADG score: two points-based scoring systems for the Johns Hopkins aggregated diagnosis groups to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011, 49: 940-947. 10.1097/MLR.0b013e318229360e.CrossRefPubMedPubMedCentral Austin PC, Walraven C: The mortality risk score and the ADG score: two points-based scoring systems for the Johns Hopkins aggregated diagnosis groups to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011, 49: 940-947. 10.1097/MLR.0b013e318229360e.CrossRefPubMedPubMedCentral
25.
go back to reference Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM: Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011, 49: 932-939. 10.1097/MLR.0b013e318215d5e2.CrossRefPubMedPubMedCentral Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM: Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011, 49: 932-939. 10.1097/MLR.0b013e318215d5e2.CrossRefPubMedPubMedCentral
26.
go back to reference Pencia MJ, D’Agostino RB, D’Agostino RB: Evaluating the added predictive ability of a new marker. From area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172. 10.1002/sim.2929.CrossRef Pencia MJ, D’Agostino RB, D’Agostino RB: Evaluating the added predictive ability of a new marker. From area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172. 10.1002/sim.2929.CrossRef
27.
go back to reference Harrell FE, Kee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.CrossRefPubMed Harrell FE, Kee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996, 15: 361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.CrossRefPubMed
28.
go back to reference Pencina MJ, D’Agostino RB: Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004, 23: 2109-2123. 10.1002/sim.1802.CrossRefPubMed Pencina MJ, D’Agostino RB: Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004, 23: 2109-2123. 10.1002/sim.1802.CrossRefPubMed
29.
go back to reference Steyerberg EW, Pencina MJ: Reclassification calculations for persons with incomplete follow-up. Ann Intern Med. 2010, 152: 195-196. 10.7326/0003-4819-152-3-201002020-00019.CrossRefPubMed Steyerberg EW, Pencina MJ: Reclassification calculations for persons with incomplete follow-up. Ann Intern Med. 2010, 152: 195-196. 10.7326/0003-4819-152-3-201002020-00019.CrossRefPubMed
30.
go back to reference Kettermann AE, Ferrucci L, Trock BJ, Metter EJ, Loeb S, Carter HB: Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer. BJU Int. 2010, 106: 1284-1290. 10.1111/j.1464-410X.2010.09363.x.CrossRefPubMedPubMedCentral Kettermann AE, Ferrucci L, Trock BJ, Metter EJ, Loeb S, Carter HB: Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer. BJU Int. 2010, 106: 1284-1290. 10.1111/j.1464-410X.2010.09363.x.CrossRefPubMedPubMedCentral
31.
go back to reference Chambless LE, Cummiskey CP, Cui G: Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med. 2011, 30: 22-38. 10.1002/sim.4026.CrossRefPubMed Chambless LE, Cummiskey CP, Cui G: Several methods to assess improvement in risk prediction models: extension to survival analysis. Stat Med. 2011, 30: 22-38. 10.1002/sim.4026.CrossRefPubMed
32.
go back to reference Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW: An updated catalog of prostate cancer predictive tools. Cancer. 2008, 113: 3075-3099. 10.1002/cncr.23908.CrossRefPubMed Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW: An updated catalog of prostate cancer predictive tools. Cancer. 2008, 113: 3075-3099. 10.1002/cncr.23908.CrossRefPubMed
33.
go back to reference Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ: Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011, 185: 869-875. 10.1016/j.juro.2010.10.057.CrossRefPubMedPubMedCentral Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ: Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011, 185: 869-875. 10.1016/j.juro.2010.10.057.CrossRefPubMedPubMedCentral
34.
go back to reference Cooperberg MR, Hilton JF, Carroll PR: The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011, 117: 5039-5046. 10.1002/cncr.26169.CrossRefPubMedPubMedCentral Cooperberg MR, Hilton JF, Carroll PR: The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011, 117: 5039-5046. 10.1002/cncr.26169.CrossRefPubMedPubMedCentral
35.
go back to reference Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM: Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006, 15: 784-792. 10.1002/pds.1214.CrossRefPubMed Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM: Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006, 15: 784-792. 10.1002/pds.1214.CrossRefPubMed
36.
go back to reference Vickers AJ: Prediction models in cancer care.CA Cancer J Clin. 2011, 23: doi:10.3322/caac.20118. [Epub ahead of print], Vickers AJ: Prediction models in cancer care.CA Cancer J Clin. 2011, 23: doi:10.3322/caac.20118. [Epub ahead of print],
37.
go back to reference Vickers AJ, Elkin EB: Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26: 565-574. 10.1177/0272989X06295361.CrossRefPubMedPubMedCentral Vickers AJ, Elkin EB: Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26: 565-574. 10.1177/0272989X06295361.CrossRefPubMedPubMedCentral
38.
go back to reference Cook NR, Ridker PM: Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009, 150: 795-802. 10.7326/0003-4819-150-11-200906020-00007.CrossRefPubMedPubMedCentral Cook NR, Ridker PM: Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009, 150: 795-802. 10.7326/0003-4819-150-11-200906020-00007.CrossRefPubMedPubMedCentral
39.
go back to reference Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010, 21: 128-138. 10.1097/EDE.0b013e3181c30fb2.CrossRefPubMedPubMedCentral Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010, 21: 128-138. 10.1097/EDE.0b013e3181c30fb2.CrossRefPubMedPubMedCentral
40.
go back to reference Vickers AJ, Cronin AM: Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology. 2010, 76: 1298-1301. 10.1016/j.urology.2010.06.019.CrossRefPubMedPubMedCentral Vickers AJ, Cronin AM: Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology. 2010, 76: 1298-1301. 10.1016/j.urology.2010.06.019.CrossRefPubMedPubMedCentral
41.
go back to reference Ladouceur M, Rahme E, Pineau CA, Joseph L: Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics. 2007, 63: 27227-27229. 10.1111/j.1541-0420.2006.00665.x.CrossRef Ladouceur M, Rahme E, Pineau CA, Joseph L: Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics. 2007, 63: 27227-27229. 10.1111/j.1541-0420.2006.00665.x.CrossRef
42.
go back to reference Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A: Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011, 64: 821-829. 10.1016/j.jclinepi.2010.10.006.CrossRefPubMed Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A: Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011, 64: 821-829. 10.1016/j.jclinepi.2010.10.006.CrossRefPubMed
Metadata
Title
Is pathology necessary to predict mortality among men with prostate-cancer?
Authors
David Margel
David R Urbach
Lorraine L Lipscombe
Chaim M Bell
Girish Kulkarni
Jack Baniel
Neil Fleshner
Peter C Austin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2014
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-014-0114-6

Other articles of this Issue 1/2014

BMC Medical Informatics and Decision Making 1/2014 Go to the issue